Abstract
SUMMARYThere is a critical need to develop small molecule inhibitors of mucin-type O-linked glycosylation. The best known reagent currently is peracetylated benzyl-GalNAc, but it is only effective at millimolar concentrations. This manuscript demonstrates that Ac5GalNTGc, a peracetylated C-2 sulfhydryl substituted GalNAc, fulfills this unmet need. When added to cultured leukocytes, breast and prostate cells, Ac5GalNTGc increased cell surface VVA-binding by ~10-fold, indicating truncation of O-glycan biosynthesis. Cytometry, mass spectrometry and Western blot analysis of HL-60 promyelocytes demonstrate that 50-80μM Ac5GalNTGc prevented elaboration of 30-60% of the O-glycans beyond the Tn-antigen (GalNAcα1-Ser/Thr) stage. The effect of the compound on N-glycans and glycosphingolipids was small. Glycan inhibition induced by Ac5GalNTGc resulted in 50-80% reduction in leukocyte sialyl-Lewis-X expression, and L-/P-selectin mediated rolling under flow. Ac5GalNTGc was pharmacologically active in mouse. It reduced neutrophil infiltration to sites of inflammation by ~60%. Overall, Ac5GalNTGc may find diverse applications as a potent inhibitor of O-glycosylation.
Publisher
Cold Spring Harbor Laboratory
Reference38 articles.
1. Inhibition of mucin-type O-glycosylation through metabolic processing and incorporation of N-thioglycolyl-D-galactosamine peracetate (Ac5GalNTGc);J Am Chem Soc,2013
2. O-linked glycans mediate apical sorting of human intestinal sucrase-isomaltase through association with lipid rafts
3. Peracetylated 4-Fluoro-glucosamine Reduces the Content and Repertoire of N- and O-Glycans without Direct Incorporation
4. Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family
5. Brockhausen, I. , and Stanley, P. (2015). O-GalNAc Glycans. In Essentials of Glycobiology, rd, A. Varki , R.D. Cummings , J.D. Esko , P. Stanley , G.W. Hart , M. Aebi , A.G. Darvill , T. Kinoshita , N.H. Packer , et al., eds. (Cold Spring Harbor (NY)), pp. 113–123.